Jaundice | Norton Children's

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Jaundice

A phase 2B, mulit-center, single dose, blinded, randomized, placebo-controlled, dose escalation, safety and efficacy trial of Stannsoporfin in neonates with Hyperbilirubinemia.

Sub-indication: Jaundice

Study Type: Drug Study

Principal Investigator: Dan Stewart, M.D.
Norton Children's Neonatology, affiliated with the UofL School of Medicine

Sponsor: Sponsor: InfaCare Pharmaceutical Corporation

Search our entire site.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Jaundice Clinical Trial